Alpha-santalol and its effects on skin cancer cell cycle
Author Information
Author(s): Zhang Xiaoying, Chen Wei, Guillermo Ruth, Chandrasekher Gudiseva, Kaushik Radhey S, Young Alan, Fahmy Hesham, Dwivedi Chandradhar
Primary Institution: South Dakota State University
Hypothesis
Does alpha-santalol affect cell cycle progression in skin cancer cells?
Conclusion
Alpha-santalol causes G2/M phase arrest in both p53-mutated and wild-type skin cancer cells, contributing to its cancer preventive efficacy.
Supporting Evidence
- Alpha-santalol decreased cell viability in A431 and UACC-62 cells.
- Treatment with alpha-santalol induced G2/M phase cell cycle arrest.
- Alpha-santalol altered the expression of cell cycle proteins critical for G2/M transition.
- Knockdown of p21 or p53 did not affect cell cycle arrest caused by alpha-santalol.
Takeaway
Alpha-santalol, a compound from sandalwood oil, helps stop skin cancer cells from growing by making them stuck in a specific part of their life cycle.
Methodology
Cell viability was assessed using MTT assay, and cell cycle distribution was analyzed using flow cytometry.
Limitations
The study primarily focuses on two cell lines and may not represent all skin cancer types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website